miR-125b inhibited epithelialal–mesenchymal transition of triple-negative breast cancer by targeting MAP2K7

Overview of attention for article published in OncoTargets and therapy, May 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 2 X users

patent: 3 patents

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,687 followers.

miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7. https://t.co/n8ntpYWWnF

Reply Repost Favourite

miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting… https://t.co/az40IsSv0w #breastcancer

Reply Repost Favourite